Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
fibrosis10255 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A23439 | 23782652 | Mol Endocrinol | Disruption of JAK2 in adipocytes impairs lipolysis and improves fatty liver in mice with elevated GH. | 2013 | Details |
| A23444 | 23775887 | Proteomics Clin Appl | Serum Mac-2 binding protein levels as a novel diagnostic biomarker for prediction of disease severity and nonalcoholic steatohepatitis. | 2013 | Details |
| A23454 | 23763360 | Liver Int | Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD). | 2013 | Details |
| A23455 | 23763294 | Alcohol Clin Exp Res | Genetic resistance to liver fibrosis on A/J mouse chromosome 17. | 2013 | Details |
| A23462 | 23759423 | J Pediatr | Serum biomarkers and transient elastography as predictors of advanced liver fibrosis in a United States cohort: the Boston children's hospital experience. | 2013 | Details |
| A23468 | 23752877 | Am J Gastroenterol | Serum cytokeratin-18 fragment levels are useful biomarkers for nonalcoholic steatohepatitis in children. | 2013 | Details |
| A23483 | 23740153 | Obes Surg | Obstructive sleep apnea is associated with fatty liver and abnormal liver enzymes: a meta-analysis. | 2013 | Details |
| A23484 | 23739675 | Int J Mol Sci | In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD). | 2013 | Details |
| A23486 | 23737773 | Int J Endocrinol | Hepatic Steatosis, Carbohydrate Intake, and Food Quotient in Patients with NAFLD. | 2013 | Details |
| A23487 | 23737763 | Gastroenterol Res Pract | Time course of the development of nonalcoholic Fatty liver disease in the Otsuka long-evans Tokushima Fatty rat. | 2013 | Details |
| A23491 | 23733885 | J Lipid Res | Deficiency of liver Comparative Gene Identification-58 causes steatohepatitis and fibrosis in mice. | 2013 | Details |
| A23495 | 23727306 | J Hepatol | Dendritic cells in liver injury and fibrosis: shortcomings and promises. | 2013 | Details |
| A23496 | 23727264 | Gastroenterology | Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease. | 2013 | Details |
| A23498 | 23721951 | Exp Gerontol | Prevalence and associated metabolic factors of fatty liver disease in the elderly. | 2013 | Details |
| A23505 | 26201789 | Hepatol Int | Impact of combined therapy with alpha-lipoic and ursodeoxycolic acid on nonalcoholic fatty liver disease: double-blind, randomized clinical trial of efficacy and safety. | 2012 | Details |
| A23509 | 26201774 | Hepatol Int | Nonalcoholic fatty liver disease following liver transplantation. | 2013 | Details |
| A23515 | 23718573 | Aliment Pharmacol Ther | Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis. | 2013 | Details |
| A23517 | 23717737 | World J Hepatol | Transient elastography: Kill two birds with one stone? | 2013 | Details |
| A23523 | 23710314 | Gut Liver | Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: An Enhanced Model of BARD Score. | 2013 | Details |
| A23525 | 23707549 | Pathol Res Pract | Presence and extent of estrogen receptor-alpha expression in patients with simple steatosis and NASH. | 2013 | Details |
| A23531 | 23703665 | Hepatology | Advanced glycation endproducts induce fibrogenic activity in nonalcoholic steatohepatitis by modulating TNF-α-converting enzyme activity in mice. | 2013 | Details |
| A23532 | 23703580 | Hepatology | Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. | 2013 | Details |
| A23534 | 23702499 | Med Ultrason | Can transient elastography be a reliable method for assessing liver fibrosis in non alcoholic steatohepatitis (NASH)? | 2013 | Details |
| A23538 | 23701387 | Hepatol Res | Osteopontin: Versatile modulator of liver diseases. | 2013 | Details |
| A23542 | 23696823 | PLoS One | Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: new insight into the probiotics for the gut-liver axis. | 2013 | Details |
| A23554 | 23686698 | Hepatology | Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients. | 2013 | Details |
| A23557 | 23682724 | Liver Int | Transgenic expression of human neutrophil peptide-1 enhances hepatic fibrosis in mice fed a choline-deficient, L-amino acid-defined diet. | 2013 | Details |
| A23562 | 23672077 | Rinsho Byori | [Clinical significance of the measurement of serum cytokeratin-18 in patients with non-alcoholic steatohepatitis]. | 2013 | Details |
| A23567 | 23668723 | Proc Nutr Soc | Ectopic fat, insulin resistance and non-alcoholic fatty liver disease. | 2013 | Details |
| A23568 | 23666886 | Obesity (Silver Spring) | Dietary modification dampens liver inflammation and fibrosis in obesity-related fatty liver disease. | 2013 | Details |
| A23570 | 23665288 | J Hepatol | A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver. | 2013 | Details |
| A23578 | 23661906 | Mediators Inflamm | Expression of inflammation-related genes is altered in gastric tissue of patients with advanced stages of NAFLD. | 2013 | Details |
| A23583 | 23657151 | Curr Opin Clin Nutr Metab Care | Carbohydrate intake and nonalcoholic fatty liver disease. | 2013 | Details |
| A23588 | 23653642 | Int J Endocrinol | Nonalcoholic Fatty liver disease, diabetes mellitus and cardiovascular disease: newer data. | 2013 | Details |
| A23589 | 23653455 | Eur J Endocrinol | Non-alcoholic fatty liver disease in common endocrine disorders. | 2013 | Details |
| A23600 | 23641933 | BMC Infect Dis | Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitors. | 2013 | Details |
| A23601 | 23638085 | PLoS One | Novel algorithm for non-invasive assessment of fibrosis in NAFLD. | 2013 | Details |
| A23611 | 23627007 | Crit Rev Immunol | Role of scavenger receptors in the pathophysiology of chronic liver diseases. | 2013 | Details |
| A23624 | 23619258 | Ann Hepatol | Validation study of systems for noninvasive diagnosis of fibrosis in nonalcoholic fatty liver disease in Latin population. | 2013 | Details |
| A23633 | 23611112 | Clin Exp Pharmacol Physiol | A high-fat diet and multiple administration of carbon tetrachloride induces liver injury and pathological features associated with non-alcoholic steatohepatitis in mice. | 2013 | Details |
| A23636 | 23607402 | Hepatol Res | Cilostazol attenuates hepatic stellate cell activation and protects mice against carbon tetrachloride-induced liver fibrosis. | 2013 | Details |
| A23638 | 23607264 | Hepatol Res | Efficacy of probucol for the treatment of non-alcoholic steatohepatitis with dyslipidemia: An open-label pilot study. | 2013 | Details |
| A23641 | 23603006 | Food Chem Toxicol | Amelioration by chicory seed extract of diabetes- and oleic acid-induced non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) via modulation of PPARα and SREBP-1. | 2013 | Details |
| A23650 | 23597924 | Med Mal Infect | Liver stiffness values in HIV-infected patients with isolated anti-hepatitis B core antibodies. | 2013 | Details |
| A23655 | 23594525 | Hum Hered | Genetic variation at NCAN locus is associated with inflammation and fibrosis in non-alcoholic fatty liver disease in morbid obesity. | 2013 | Details |
| A23657 | 23592668 | Obesity (Silver Spring) | Nonalcoholic fatty liver disease in severely obese adolescent and adult patients. | 2013 | Details |
| A23659 | 23592516 | Mol Pharmacol | Nrf2 activators attenuate the progression of nonalcoholic steatohepatitis-related fibrosis in a dietary rat model. | 2013 | Details |
| A23674 | 23576902 | ScientificWorldJournal | Current concepts and management approaches in nonalcoholic fatty liver disease. | 2013 | Details |
| A23681 | 23567086 | J Hepatol | Decoding cell death signals in liver inflammation. | 2013 | Details |
| A23682 | 23567085 | J Hepatol | Cannabinoid signaling and liver therapeutics. | 2013 | Details |
| A23686 | 23564711 | Radiology | Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography. | 2013 | Details |
| A23691 | 23560860 | Liver Int | Associations of depression, anxiety and antidepressants with histological severity of nonalcoholic fatty liver disease. | 2013 | Details |
| A23692 | 23560827 | Liver Int | The role of transient elastography in the detection of liver disease in patients with chronic pancreatitis. | 2013 | Details |
| A23694 | 23560443 | Int J Exp Pathol | Inhibition of Glutaminyl Cyclases alleviates CCL2-mediated inflammation of non-alcoholic fatty liver disease in mice. | 2013 | Details |
| A23701 | 23555578 | PLoS One | NIKEI: a new inexpensive and non-invasive scoring system to exclude advanced fibrosis in patients with NAFLD. | 2013 | Details |
| A23703 | 23554788 | J Biomed Res | Lipoprotein metabolism in nonalcoholic fatty liver disease. | 2012 | Details |
| A23710 | 23547829 | Nutr J | Plasmatic higher levels of homocysteine in non-alcoholic fatty liver disease (NAFLD). | 2013 | Details |
| A23723 | 23535911 | Hum Genet | Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan. | 2013 | Details |
| A23724 | 23534297 | Med Pregl | [Cardiovascular disease risk factors in patients with non-alcoholic fatty liver disease]. | 2013 | Details |
| A23727 | 23530957 | BMC Pediatr | Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets. | 2013 | Details |
| A23728 | 23529597 | Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz | [Non-alcoholic fatty liver disease in obese children and adolescents]. | 2013 | Details |
| A23729 | 23529326 | Rom J Morphol Embryol | Correlations between anthropometric and serologic elements of metabolic syndrome and histopathologic features of nonalcoholic fatty liver disease. | 2013 | Details |
| A23736 | 23519653 | Hepatol Int | Hepatic angiogenesis and fibrosis are common features in morbidly obese patients. | 2011 | Details |
| A23737 | 23518490 | J Pediatr Gastroenterol Nutr | Serum bilirubin level is inversely associated with nonalcoholic steatohepatitis in children. | 2013 | Details |
| A23740 | 23516679 | Can J Gastroenterol | A health technology assessment of transient elastography in adult liver disease. | 2013 | Details |
| A23743 | 23515587 | Eur J Nutr | Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways. | 2013 | Details |
| A23744 | 23514999 | Minerva Med | Recurrent hepatitis C and non-alcoholic fatty liver disease in transplanted patients: a review. | 2013 | Details |
| A23746 | 23512965 | Obesity (Silver Spring) | Metabolomic signatures in lipid-loaded HepaRGs reveal pathways involved in steatotic progression. | 2013 | Details |
| A23747 | 23512881 | Obesity (Silver Spring) | A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population. | 2013 | Details |
| A23749 | 23512600 | Obesity (Silver Spring) | Serum hepcidin levels are associated with obesity but not liver disease. | 2013 | Details |
| A23752 | 23510120 | Hepatol Res | Clinical usefulness of non-protein respiratory quotient measurement in non-alcoholic fatty liver disease. | 2013 | Details |
| A23753 | 23510093 | Hepatol Res | Novel effect of ezetimibe to inhibit the development of non-alcoholic fatty liver disease in Fatty Liver Shionogi mouse. | 2013 | Details |
| A23754 | 23509615 | J Obes | Platelet counts and liver enzymes after bariatric surgery. | 2013 | Details |
| A23758 | 23507799 | Nat Rev Gastroenterol Hepatol | Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. | 2013 | Details |
| A23766 | 23503837 | J Gastroenterol | Oral choline tolerance test as a novel noninvasive method for predicting nonalcoholic steatohepatitis. | 2013 | Details |
| A23768 | 23500152 | J Hepatol | Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndrome. | 2013 | Details |
| A23779 | 23486619 | Med Ultrason | Quantitative measurement of ultrasound attenuation and Hepato-Renal Index in Non-Alcoholic Fatty Liver Disease. | 2013 | Details |
| A23780 | 23486573 | Bull Exp Biol Med | Characteristics of heme oxygenase-1 expression in rat hepatocytes during the development of nonalcoholic steatohepatitis. | 2013 | Details |
| A23781 | 23485520 | J Hepatol | The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. | 2013 | Details |
| A23782 | 23484035 | PLoS One | Susceptibility and gene interaction study of the angiotensin II type 1 receptor (AGTR1) gene polymorphisms with non-alcoholic fatty liver disease in a multi-ethnic population. | 2013 | Details |
| A23783 | 23483818 | World J Gastroenterol | From fatty liver to fibrosis: a tale of "second hit". | 2013 | Details |
| A23784 | 23482703 | World J Gastroenterol | NAFLD fibrosis score: a prognostic predictor for mortality and liver complications among NAFLD patients. | 2013 | Details |
| A23785 | 23482433 | Korean J Pediatr | Noninvasive diagnosis of pediatric nonalcoholic fatty liver disease. | 2013 | Details |
| A23786 | 23482247 | World J Gastroenterol | Fructose as a key player in the development of fatty liver disease. | 2013 | Details |
| A23787 | 23480804 | Expert Opin Med Diagn | Liver fibrosis in patients with non-alcoholic fatty liver disease: diagnostic options in clinical practice. | 2012 | Details |
| A23788 | 23480803 | Expert Opin Med Diagn | Transient elastography and serum biomarkers: two-step screening methods for liver fibrosis in non-alcoholic fatty liver disease before liver biopsy. | 2012 | Details |
| A23790 | 23478936 | J Gastroenterol | Serum metabolomic profile and potential biomarkers for severity of fibrosis in nonalcoholic fatty liver disease. | 2013 | Details |
| A23791 | 23478717 | Nutr Hosp | Influence of G1359A polimorphysm of the cannabinoid receptor gene (CNR1) on insulin resistance and adipokines in patients with non alcoholic fatty liver disease. | 2013 | Details |
| A23795 | 23477499 | Antioxid Redox Signal | Peroxiredoxin 4 protects against nonalcoholic steatohepatitis and type 2 diabetes in a nongenetic mouse model. | 2013 | Details |
| A23800 | 23467489 | Lab Anim | Gender and strain-specific differences in the development of steatosis in rats. | 2013 | Details |
| A23804 | 23461136 | Adv Clin Chem | Toll-like receptors in liver disease. | 2013 | Details |
| A23812 | 23453039 | Metabolism | Involvement of regucalcin in lipid metabolism and diabetes. | 2013 | Details |
| A23813 | 23452341 | Br J Clin Pharmacol | The hepatic cannabinoid 1 receptor as a modulator of hepatic energy state and food intake. | 2014 | Details |
| A23826 | 25755474 | J Clin Exp Hepatol | Successful Treatment of Rapid Onset, Symptomatic de novo Non-alcoholic Steatohepatitis Following Liver Transplantation: A Case Report. | 2013 | Details |
| A23828 | 23442837 | J Clin Gastroenterol | Stepwise combination of simple noninvasive fibrosis scoring systems increases diagnostic accuracy in nonalcoholic fatty liver disease. | 2013 | Details |
| A23830 | 23441892 | Aliment Pharmacol Ther | Phase II clinical trial of phlebotomy for non-alcoholic fatty liver disease. | 2013 | Details |
| A23835 | 23439508 | Acta Med Okayama | A prospective study of long-term outcomes in female patients with nonalcoholic steatohepatitis using age- and body mass index-matched cohorts. | 2013 | Details |
| A23836 | 23439261 | J Hepatol | The liver diseases of lipodystrophy: the long-term effect of leptin treatment. | 2013 | Details |
| A23845 | 23431468 | ISRN Endocrinol | Roles for PI3K/AKT/PTEN Pathway in Cell Signaling of Nonalcoholic Fatty Liver Disease. | 2013 | Details |
| A23846 | 23431426 | J Obes | Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance? | 2013 | Details |